Skip to main content
Supplement ScienceSupplementScience

Benefits of Red Yeast Rice

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • LDL cholesterol reduction — a 2014 meta-analysis in Atherosclerosis (13 RCTs, n=804) found red yeast rice reduced LDL-C by an average of 1.02 mmol/L (~39 mg/dL), comparable to low-dose statin therapy.
  • Total cholesterol improvement — the same meta-analysis reported significant total cholesterol reductions averaging 0.97 mmol/L across studies, with benefits appearing within 4-8 weeks.
  • Statin-intolerant patients — Becker et al. (2009) in Annals of Internal Medicine showed that red yeast rice 1800mg twice daily lowered LDL by 21.3% in patients who had discontinued statins due to myalgia, with minimal side effects.
  • Cardiovascular event reduction — the landmark CCSPS trial (n=4,870) demonstrated a 45% reduction in recurrent cardiac events over 4.5 years in post-MI patients taking a purified red yeast rice extract (Xuezhikang).

What the Research Says

Red Yeast Rice is a natural supplement that has been extensively studied for its lipid-lowering effects. The CCSPS trial by Lu et al. (2008) remains the largest cardiovascular outcomes study of any supplement, demonstrating significant reductions in cardiac events and mortality. A meta-analysis by Li et al. (2014) confirmed LDL-C reductions of 1.02 mmol/L across 13 randomized controlled trials. Becker et al. (2009) further highlighted its efficacy in statin-intolerant patients.

Recent studies reinforce these findings. Trogkanis et al. (2024) conducted a systematic review and meta-analysis of 14 double-blind clinical trials, showing significant reductions in total cholesterol (-37.43 mg/dL, p<0.05) and LDL-C (-35.82 mg/dL, p<0.05). Rahmani et al. (2023) analyzed 24 randomized-controlled trials involving 3623 participants, indicating that Red Yeast Rice lowers total cholesterol, LDL-C, triglycerides, and raises HDL-C.

Safety is a critical consideration. Fogacci et al. (2019) reviewed 53 RCTs with 8535 participants, concluding that Red Yeast Rice supplementation is safe. However, variability among products persists, with some containing citrinin, a nephrotoxic contaminant. Standardized, third-party tested products are essential to ensure efficacy and safety.

Xuezhikang has been identified as particularly effective for reducing total and LDL cholesterol in hyperlipidaemia patients (Xu et al., 2022). Overall, Red Yeast Rice is a valuable option for managing dyslipidemia, supported by evidence across various populations.

Related Conditions

Heart HealthHigh Cholesterol
Ready to try Red Yeast Rice?
See our independently tested and ranked picks
Full Red Yeast Rice Guide

References

  1. Meta-analysisLi Y, Jiang L, Jia Z, Xin W, Yang S, Yang Q, Wang L (2014). A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia. PLoS ONE. DOI PubMed
  2. RCTBecker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ (2009). Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Annals of Internal Medicine. DOI PubMed
  3. Meta-analysisTrogkanis E, Karalexi MA, Sergentanis TN, Kornarou E, et al. (2024). Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis.. Nutrients. DOI PubMed
  4. Ma ZY, Yang SP, Li Y, Xu TT, et al. (2024). Associations between the use of red yeast rice preparations and adverse health outcomes: An umbrella review of meta-analyses of randomized controlled trials.. Journal of integrative medicine. DOI PubMed
  5. Meta-analysisRahmani P, Melekoglu E, Tavakoli S, Malekpour Alamdari N, et al. (2023). Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials.. Expert review of clinical pharmacology. DOI PubMed
  6. Xu G, Lin M, Dai X, Hu J (2022). Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials.. Endocrinology, diabetes & metabolism. DOI PubMed
  7. Wu B, Huang JF, He BJ, Huang CW, et al. (2020). Promotion of Bone Formation by Red Yeast Rice in Experimental Animals: A Systematic Review and Meta-Analysis.. BioMed research international. DOI PubMed
Show 4 more references
  1. Sungthong B, Yoothaekool C, Promphamorn S, Phimarn W (2020). Efficacy of red yeast rice extract on myocardial infarction patients with borderline hypercholesterolemia: A meta-analysis of randomized controlled trials.. Scientific reports. DOI PubMed
  2. Meta-analysisFogacci F, Banach M, Mikhailidis DP, Bruckert E, et al. (2019). Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials.. Pharmacological research. DOI PubMed
  3. Peng D, Fong A, Pelt AV (2017). Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults.. The American journal of nursing. DOI PubMed
  4. Millán J, Cicero AF, Torres F, Anguera A (2016). Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials.. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. DOI PubMed